JP2017516770A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017516770A5 JP2017516770A5 JP2016568504A JP2016568504A JP2017516770A5 JP 2017516770 A5 JP2017516770 A5 JP 2017516770A5 JP 2016568504 A JP2016568504 A JP 2016568504A JP 2016568504 A JP2016568504 A JP 2016568504A JP 2017516770 A5 JP2017516770 A5 JP 2017516770A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- cellulose
- composition according
- methyl
- ectoine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 21
- KIIBBJKLKFTNQO-WHFBIAKZSA-N 5-hydroxyectoine Chemical compound CC1=N[C@H](C(O)=O)[C@@H](O)CN1 KIIBBJKLKFTNQO-WHFBIAKZSA-N 0.000 claims 3
- WQXNXVUDBPYKBA-UHFFFAOYSA-N Ectoine Natural products CC1=NCCC(C(O)=O)N1 WQXNXVUDBPYKBA-UHFFFAOYSA-N 0.000 claims 3
- 150000001408 amides Chemical class 0.000 claims 3
- WQXNXVUDBPYKBA-YFKPBYRVSA-N ectoine Chemical compound CC1=[NH+][C@H](C([O-])=O)CCN1 WQXNXVUDBPYKBA-YFKPBYRVSA-N 0.000 claims 3
- 150000002148 esters Chemical class 0.000 claims 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims 3
- -1 polyimines Polymers 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000002562 thickening agent Substances 0.000 claims 3
- 235000010443 alginic acid Nutrition 0.000 claims 2
- 229920000615 alginic acid Polymers 0.000 claims 2
- 229920003086 cellulose ether Polymers 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- GOLXRNDWAUTYKT-UHFFFAOYSA-N 3-(1H-indol-3-yl)propanoic acid Chemical compound C1=CC=C2C(CCC(=O)O)=CNC2=C1 GOLXRNDWAUTYKT-UHFFFAOYSA-N 0.000 claims 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 claims 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 1
- 229920001287 Chondroitin sulfate Polymers 0.000 claims 1
- 229920000896 Ethulose Polymers 0.000 claims 1
- 239000001856 Ethyl cellulose Substances 0.000 claims 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims 1
- 239000001859 Ethyl hydroxyethyl cellulose Substances 0.000 claims 1
- 229920002683 Glycosaminoglycan Polymers 0.000 claims 1
- 229920002907 Guar gum Polymers 0.000 claims 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims 1
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 claims 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 claims 1
- 208000022873 Ocular disease Diseases 0.000 claims 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 claims 1
- 239000004952 Polyamide Substances 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 1
- 102000016611 Proteoglycans Human genes 0.000 claims 1
- 108010067787 Proteoglycans Proteins 0.000 claims 1
- 229920002125 Sokalan® Polymers 0.000 claims 1
- MKRNVBXERAPZOP-UHFFFAOYSA-N Starch acetate Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OC(C)=O)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 MKRNVBXERAPZOP-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000000783 alginic acid Substances 0.000 claims 1
- 229960001126 alginic acid Drugs 0.000 claims 1
- 150000004781 alginic acids Chemical class 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 1
- 235000010418 carrageenan Nutrition 0.000 claims 1
- 239000000679 carrageenan Substances 0.000 claims 1
- 229920001525 carrageenan Polymers 0.000 claims 1
- 229940113118 carrageenan Drugs 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 235000010980 cellulose Nutrition 0.000 claims 1
- 229940082500 cetostearyl alcohol Drugs 0.000 claims 1
- 229960000541 cetyl alcohol Drugs 0.000 claims 1
- 229940059329 chondroitin sulfate Drugs 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 229920001249 ethyl cellulose Polymers 0.000 claims 1
- 235000019325 ethyl cellulose Nutrition 0.000 claims 1
- 235000019326 ethyl hydroxyethyl cellulose Nutrition 0.000 claims 1
- 235000010944 ethyl methyl cellulose Nutrition 0.000 claims 1
- 239000000665 guar gum Substances 0.000 claims 1
- 235000010417 guar gum Nutrition 0.000 claims 1
- 229960002154 guar gum Drugs 0.000 claims 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- 229920013818 hydroxypropyl guar gum Polymers 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- 206010023332 keratitis Diseases 0.000 claims 1
- 201000010666 keratoconjunctivitis Diseases 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
- 235000010981 methylcellulose Nutrition 0.000 claims 1
- 229920003087 methylethyl cellulose Polymers 0.000 claims 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims 1
- 239000002086 nanomaterial Substances 0.000 claims 1
- 239000006199 nebulizer Substances 0.000 claims 1
- 229920002401 polyacrylamide Polymers 0.000 claims 1
- 239000004584 polyacrylic acid Substances 0.000 claims 1
- 229920002647 polyamide Polymers 0.000 claims 1
- 229920000570 polyether Polymers 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims 1
- 229920001285 xanthan gum Polymers 0.000 claims 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102014007423.4A DE102014007423A1 (de) | 2014-05-22 | 2014-05-22 | Zusammensetzung zur Behandlung des Auges |
| DE102014007423.4 | 2014-05-22 | ||
| PCT/EP2015/061434 WO2015177353A1 (de) | 2014-05-22 | 2015-05-22 | Zusammensetzung zur behandlung des auges |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017516770A JP2017516770A (ja) | 2017-06-22 |
| JP2017516770A5 true JP2017516770A5 (OSRAM) | 2017-08-03 |
Family
ID=53433159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016568504A Pending JP2017516770A (ja) | 2014-05-22 | 2015-05-22 | 眼の治療用組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20170173012A1 (OSRAM) |
| EP (2) | EP3977998A1 (OSRAM) |
| JP (1) | JP2017516770A (OSRAM) |
| CN (1) | CN106456537A (OSRAM) |
| CA (1) | CA2949203C (OSRAM) |
| DE (1) | DE102014007423A1 (OSRAM) |
| ES (1) | ES2906431T3 (OSRAM) |
| PL (1) | PL3145511T3 (OSRAM) |
| RU (1) | RU2016150412A (OSRAM) |
| WO (1) | WO2015177353A1 (OSRAM) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102016203696A1 (de) * | 2016-03-07 | 2017-09-07 | Ursapharm Arzneimittel Gmbh | Ophthalmologische Zusammensetzung |
| DE102016204472A1 (de) * | 2016-03-17 | 2017-09-21 | Ursapharm Arzneimittel Gmbh | Kit zur kosmetischen Behandlung des Auges und der Haut und Kosmetikum zur Anwendung am Auge und auf der Haut |
| EP3827818A1 (en) * | 2019-11-26 | 2021-06-02 | Warszawskie Zaklady Farmaceutyczne Polfa S.A. | Ophthalmic composition |
| CN111467349B (zh) * | 2020-05-14 | 2021-06-01 | 华熙生物科技股份有限公司 | 人工泪液及其制备方法 |
| CN111991415B (zh) * | 2020-09-11 | 2022-03-01 | 华熙生物科技股份有限公司 | 一种眼部护理组合物及其制备方法和用途 |
| US12012238B2 (en) | 2021-05-26 | 2024-06-18 | Bausch + Lomb Ireland Limited | Packaging solutions |
| CN116139067B (zh) * | 2021-11-22 | 2024-03-22 | 华熙生物科技股份有限公司 | 透明质酸锌形成凝胶的方法及含有透明质酸锌的滴眼凝胶及其制备 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3383704B2 (ja) * | 1993-04-02 | 2003-03-04 | わかもと製薬株式会社 | 安定なリポソーム水分散液 |
| US5698533A (en) * | 1994-07-26 | 1997-12-16 | Kang; Meng-Che | Ophthalmic pharmaceutical composition |
| ATE202930T1 (de) * | 1994-12-19 | 2001-07-15 | Taisho Pharmaceutical Co Ltd | Augentropfen mit liposomen |
| JPH0977656A (ja) * | 1995-09-14 | 1997-03-25 | Toshihiro Handa | 点眼用エアゾル組成物 |
| GB9716376D0 (en) * | 1997-08-01 | 1997-10-08 | Isis Innovation | Artificial tear formulation |
| DE10006578C2 (de) | 2000-02-14 | 2002-10-31 | Bitop Ag | Verwendung von kompatiblen Soluten als Inhibitoren des enzymatischen Abbaus von makromolekularen Biopolymeren |
| DE10330243A1 (de) | 2003-07-03 | 2005-01-20 | bitop Aktiengesellschaft für biotechnische Optimierung | Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von Arzneimitteln zur äusserlichen Behandlung der Neurodermitis |
| CN101065139A (zh) * | 2004-10-09 | 2007-10-31 | 扶瑞药业股份有限公司 | 眼用药剂递送系统 |
| DE102006056766A1 (de) | 2006-12-01 | 2008-06-05 | Bitop Ag | Verwendung von kompatiblen Soluten |
| ZA200904917B (en) * | 2007-02-09 | 2010-09-29 | Alcon Inc | Ophthalmic compositions containing a synergistic combination of three polymers |
| DE102007052380A1 (de) * | 2007-10-31 | 2009-05-07 | Bitop Ag | Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten |
| ES2356883B1 (es) * | 2008-07-24 | 2012-02-22 | Bcn Peptides, S.A. | Composición para el tratamiento del dolor y/o la inflamación. |
| CN101491525A (zh) * | 2009-03-03 | 2009-07-29 | 山东大学 | 四氢嘧啶在制备治疗干眼症药物中的应用 |
| JP5659388B2 (ja) * | 2009-06-10 | 2015-01-28 | マイトテック ソシエテ アノニム | 医学及び獣医眼科の使用のための医薬組成物 |
| US20110300097A1 (en) * | 2010-06-04 | 2011-12-08 | Al-Qahtani Ahmed H | Method And Composition For The Treatment Of Moderate To Severe Keratoconjunctivitis Sicca |
| DE102011113059A1 (de) * | 2011-09-09 | 2013-03-14 | Bitop Ag | Therapeutische Anwendungen von Ectoin |
-
2014
- 2014-05-22 DE DE102014007423.4A patent/DE102014007423A1/de active Pending
-
2015
- 2015-05-22 CA CA2949203A patent/CA2949203C/en active Active
- 2015-05-22 PL PL15729760T patent/PL3145511T3/pl unknown
- 2015-05-22 ES ES15729760T patent/ES2906431T3/es active Active
- 2015-05-22 JP JP2016568504A patent/JP2017516770A/ja active Pending
- 2015-05-22 EP EP21209678.8A patent/EP3977998A1/de active Pending
- 2015-05-22 RU RU2016150412A patent/RU2016150412A/ru not_active Application Discontinuation
- 2015-05-22 EP EP15729760.7A patent/EP3145511B1/de active Active
- 2015-05-22 US US15/312,970 patent/US20170173012A1/en not_active Abandoned
- 2015-05-22 WO PCT/EP2015/061434 patent/WO2015177353A1/de not_active Ceased
- 2015-05-22 CN CN201580026099.5A patent/CN106456537A/zh active Pending
-
2021
- 2021-08-05 US US17/395,320 patent/US20220133719A1/en not_active Abandoned
-
2024
- 2024-12-31 US US19/006,532 patent/US20250195515A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017516770A5 (OSRAM) | ||
| RU2016150412A (ru) | Композиция для лечения глаз | |
| MX381004B (es) | Composiciones de fenfluramina y métodos de preparación de las mismas. | |
| HRP20160135T1 (hr) | Derivati 2-(2,4,5-supstituiranog-anilino) pirimidina kao modulatori egfr koji su korisni za lijeäśenje raka | |
| PE20160665A1 (es) | Derivados 11-hidroxilo de acidos biliares y conjugados de aminoacidos de los mismos como moduladores del receptor de farnesoid x | |
| EA201592256A1 (ru) | Производные имидазопирролидинона и их применение при лечении заболеваний | |
| HRP20250119T1 (hr) | Kdm1a inhibitor i njegova primjena u terapiji | |
| RU2018112239A (ru) | Фармацевтическая композиция на основе трамадола для офтальмологического применения | |
| MX2020005942A (es) | Delgada pelicula oral con alta carga de agente activo. | |
| PE20200698A1 (es) | Gel que comprende clorhexidina | |
| EA200970348A1 (ru) | Новые инъецируемые депо-композиции и способ получения таких композиций | |
| WO2011141929A3 (en) | Aqueous pharmaceutical compositions of fluticasone and olopatadine | |
| NZ704604A (en) | Nep inhibitors for treating diseases characterized by atrial enlargement or remodeling | |
| RU2012155711A (ru) | Жидкий назальный спрей, содержащий налтрексон в низкой дозе | |
| MY180145A (en) | Cenicriviroc compositions and methods of making and using the same | |
| EA201591957A1 (ru) | Производные глутаримидов, их применение, фармацевтическая композиция на их основе, способы их получения | |
| RU2013124024A (ru) | Фармацевтическая композиция, содержащая мометазона фуроат и азеластина гидрохлорид, назального введения | |
| MX390671B (es) | Composicion de suspension oftalmica. | |
| HRP20220683T1 (hr) | Liječenje parkinsonove bolesti | |
| FI3666258T3 (fi) | Menetelmä prader-willin oireyhtymän hoitamiseksi | |
| JP2013534527A5 (OSRAM) | ||
| JP2013532035A5 (OSRAM) | ||
| HRP20192010T1 (hr) | Muskarinski antagonisti i njihove kombinacije za liječenje bolesti dišnih puteva kod konja | |
| JP2019142974A5 (OSRAM) | ||
| FI3248597T3 (fi) | Terapeuttinen aine sensorineuraaliseen kuulonmenetykseen |